Inhibrx Biosciences, Inc. (INBX) stock news · rev $1.3M
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
This INBX news page leads with what Inhibrx Biosciences, Inc. filed — not a scraped headline mill.
No cached 8-K sentence for INBX yet. We will not pad this page with generic market recap.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the INBX stock page; for the tape open the quote page.
INBX stock news FAQ
What are INBX's latest revenue and net income?
Latest cached Inhibrx Biosciences, Inc. (INBX) revenue for Dec 31, 2025 was $1.3M. Net income was -$140.1M. Statements: https://lician.com/financials/inbx
How did INBX revenue change from the prior cached period?
Cached Inhibrx Biosciences, Inc. (INBX) revenue was up 550.0% from $200.0K (Dec 31, 2024) to $1.3M (Dec 31, 2025). Statements: https://lician.com/financials/inbx
What is INBX's market cap?
Inhibrx Biosciences, Inc. (INBX) market cap is $1.28B on the latest cached fundamentals snapshot.
What kind of company is INBX?
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Where is INBX stock news listed?
Cached stock news for Inhibrx Biosciences, Inc. (INBX) is listed at https://lician.com/news/inbx. Filings: https://lician.com/sec/inbx
Not investment advice.